Shingles Vaccine Cuts Heart Attack and Stroke Risk
Groundbreaking UK research finds the shingles vaccine Zostavax is linked to a dramatically lower risk of cardiovascular events, offering unexpected protection for older adults.
Groundbreaking UK research finds the shingles vaccine Zostavax is linked to a dramatically lower risk of cardiovascular events, offering unexpected protection for older adults.
A major new study suggests the shingles vaccine does more than prevent the painful rash—it could dramatically cut the risk of heart attacks and strokes, even for younger adults.